Senators tell FDA to pick up the pace on biosimilar guidelines By Steven Ross Johnson | September 17, 2015

Members of a Senate Health, Education, Labor and Pensions subcommittee Thursday urged the Food and Drug Administration to set biosimilar rules to avoid the kind of challenges generic drugs faced when introduced to the market three decades ago.  http://www.modernhealthcare.com/article/20150917/NEWS/150919896?utm_source=modernhealthcare&utm_medium=email&utm_content=externalURL&utm_campaign=am